Oxford BioMedica plc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oxford BioMedica plc with three other
companies in this sector in UNITED KINGDOM :
Worldwide Healthcare Trust Plc
sales of £20.46 million [US$28.22 million]
Open Orphan PLC
(£20.60 million [US$28.42 million]
of which 100%
was Consulting and Clinical trail services), and
(£86.39 million [US$119.16 million]
of which 64%
Sales were up sharply during the second
quarter of 2021 versus the previous year's second quarter.
During the second
quarter of 2021, sales at Oxford BioMedica plc totalled
an increase of 139.1%
from the £33.98 million in sales at the company during the second quarter of 2020.
During the year ended December of 2020, sales at
Oxford BioMedica plc were £87.73 million (US$121.00 million).
increase of 36.9%
versus 2019, when the company's sales were £64.06 million.
Sales of Platform saw an increase
70.8% in 2020, from
£51.00 million to £87.12 million.
Not all segments of Oxford BioMedica plc experienced an increase in sales in 2020:
sales of Products fell 95.3% to £611,000.00 .